🇺🇸 FDA
Patent

US 10322213

Compositions and methods for altering the rate of hydrolysis of cured oil-based materials

granted A61PA61P29/00A61P31/00

Quick answer

US patent 10322213 (Compositions and methods for altering the rate of hydrolysis of cured oil-based materials) held by ATRIUM MEDICAL CORPORATION expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ATRIUM MEDICAL CORPORATION
Grant date
Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61P, A61P29/00, A61P31/00, A61P35/00